Atea Pharmaceuticals (AVIR) Shares Repurchased (2025)

Atea Pharmaceuticals (AVIR) recorded quarterly Shares Repurchased of $11.4 million in Q3 2025.

Atea Pharmaceuticals (AVIR) Shares Repurchased (2025) Analysis & Trends

Atea Pharmaceuticals' Shares Repurchased history runs 1 years deep, the most recent figure standing at $11.4 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 839,896.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 336.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Atea Pharmaceuticals 347.28 Mn 347.28 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 11.43 Mn
Sep 30, 2025 11.43 Mn